AbbVie (ABBV) News Today $171.49 -2.21 (-1.27%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Top Biotech Stocks To Follow Now - January 20thAbbVie, Thermo Fisher Scientific, Vertex Pharmaceuticals, Danaher, and Cencora are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that are engaged in the development and commercialization of biotechnologies, including phJanuary 20 at 2:10 PM | marketbeat.comAbbVie Inc. (ABBV): A Bull Case TheoryJanuary 20 at 8:22 AM | insidermonkey.comDiversify Advisory Services LLC Sells 6,472 Shares of AbbVie Inc. (NYSE:ABBV)Diversify Advisory Services LLC lowered its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 26.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,105 shares of the company's stock after selling 6,472 sharesJanuary 20 at 6:22 AM | marketbeat.comDiversify Wealth Management LLC Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)Diversify Wealth Management LLC lifted its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 62.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 25,635 shares of the company's stock after buying an addiJanuary 20 at 6:22 AM | marketbeat.comRoundAngle Advisors LLC Invests $1.73 Million in AbbVie Inc. (NYSE:ABBV)RoundAngle Advisors LLC bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 9,736 shares of the company's stock, valued at approximately $1,73January 20 at 5:50 AM | marketbeat.comBrady Martz Wealth Solutions LLC Takes Position in AbbVie Inc. (NYSE:ABBV)Brady Martz Wealth Solutions LLC purchased a new position in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 6,001 shares of the company's stock, valued at approximateJanuary 20 at 5:15 AM | marketbeat.comArtemis Investment Management LLP Has $85.98 Million Holdings in AbbVie Inc. (NYSE:ABBV)Artemis Investment Management LLP lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 633.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 483,827 shares of the company's stock after buying anJanuary 20 at 5:07 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Purchased by Ameritas Advisory Services LLCAmeritas Advisory Services LLC raised its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 18.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,936 shares of the company's stock after purchasingJanuary 20 at 4:24 AM | marketbeat.comTop 4 Immunology Stocks Poised For Growth In 2025January 19 at 5:04 PM | seekingalpha.comAbbVie Inc. (NYSE:ABBV) Shares Bought by Wealth Alliance Advisory Group LLCWealth Alliance Advisory Group LLC lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 21.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,276 shares of the company's stock afJanuary 19 at 6:52 AM | marketbeat.comJackson Square Capital LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV)Jackson Square Capital LLC cut its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 36.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 16,284 shares of the company's stock after selling 9,502 shares during the quarter. Jackson SquareJanuary 19 at 5:57 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by HB Wealth Management LLCHB Wealth Management LLC boosted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 12.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,938 shares of the company's stock after acquirinJanuary 19 at 5:30 AM | marketbeat.comFinancial & Tax Architects LLC Increases Stock Holdings in AbbVie Inc. (NYSE:ABBV)Financial & Tax Architects LLC boosted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 37,082 shares of the company's stock after buying an additional 1,662 shares during the period. AbJanuary 19 at 5:29 AM | marketbeat.comTrust Co. of Vermont Sells 2,907 Shares of AbbVie Inc. (NYSE:ABBV)Trust Co. of Vermont trimmed its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 169,583 shares of the company's stock after sellingJanuary 19 at 5:29 AM | marketbeat.comCohen Klingenstein LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)Cohen Klingenstein LLC trimmed its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 64.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,000 shares of the company's stock after selling 32,500 shares durJanuary 19 at 5:18 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) is Verity & Verity LLC's 6th Largest PositionVerity & Verity LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 171,852 shares of the company's stocJanuary 19 at 5:18 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Integrated Investment Consultants LLCIntegrated Investment Consultants LLC raised its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 177,739 shares of the company's stock after purchasing an additional 8,550 shares during theJanuary 19 at 5:06 AM | marketbeat.comAvanza Fonder AB Acquires Shares of 8,443 AbbVie Inc. (NYSE:ABBV)Avanza Fonder AB bought a new position in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 8,443 shares of the company's stock, valued at approximately $1,500,000. Several other lJanuary 19 at 4:18 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Short Interest UpdateAbbVie Inc. (NYSE:ABBV - Get Free Report) was the recipient of a significant drop in short interest in December. As of December 31st, there was short interest totalling 17,000,000 shares, a drop of 8.3% from the December 15th total of 18,530,000 shares. Based on an average daily volume of 6,190,000 shares, the days-to-cover ratio is presently 2.7 days.January 18 at 11:58 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Position Raised by Lake Street Private Wealth LLCLake Street Private Wealth LLC raised its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 11.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,110 shares of the company's stock after purcJanuary 18 at 8:27 AM | marketbeat.comBrooklyn Investment Group Has $2.73 Million Holdings in AbbVie Inc. (NYSE:ABBV)Brooklyn Investment Group grew its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 29.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,338 shares of the company's stock after acquiring an additional 3,50January 18 at 7:05 AM | marketbeat.comGrant GrossMendelsohn LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV)Grant GrossMendelsohn LLC reduced its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 18.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,623 shares of the company's stock after selling 1,744 shares during theJanuary 18 at 6:11 AM | marketbeat.comWedge Capital Management L L P NC Trims Stock Holdings in AbbVie Inc. (NYSE:ABBV)Wedge Capital Management L L P NC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 160,799 shares of the company's stock after selling 3,753 shareJanuary 18 at 6:11 AM | marketbeat.comHouseholder Group Estate & Retirement Specialist LLC Reduces Position in AbbVie Inc. (NYSE:ABBV)Householder Group Estate & Retirement Specialist LLC lowered its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 40.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,169 shares of the company's stJanuary 18 at 5:59 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Holdings Raised by Relyea Zuckerberg Hanson LLCRelyea Zuckerberg Hanson LLC increased its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 136.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,090 shares of the company's stock after purchasingJanuary 18 at 5:36 AM | marketbeat.comTompkins Financial Corp Buys 1,956 Shares of AbbVie Inc. (NYSE:ABBV)Tompkins Financial Corp increased its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 5.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,727 shares of the company's stock after acquiring an additionJanuary 18 at 5:25 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Purchased by Yarger Wealth Strategies LLCYarger Wealth Strategies LLC increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 146.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,422 shares of the company's stock afterJanuary 18 at 5:17 AM | marketbeat.comChannel Wealth LLC Has $1.68 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV)Channel Wealth LLC lifted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 87.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,428 shares of the company's stock after purchasing anJanuary 18 at 5:08 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Stock Holdings Lifted by KMG Fiduciary Partners LLCKMG Fiduciary Partners LLC raised its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,277 shares of the company's stock after purJanuary 18 at 5:08 AM | marketbeat.comAbbVie price target lowered to $212 from $221 at GuggenheimJanuary 17 at 4:33 PM | markets.businessinsider.comDecker Retirement Planning Inc. Purchases New Position in AbbVie Inc. (NYSE:ABBV)Decker Retirement Planning Inc. acquired a new position in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,079 shares of the company's stocJanuary 17 at 8:05 AM | marketbeat.comIncome & Growth: 3 Of The Best Dividend Stocks For Any MarketJanuary 17 at 8:00 AM | seekingalpha.comEmpirical Asset Management LLC Boosts Stake in AbbVie Inc. (NYSE:ABBV)Empirical Asset Management LLC increased its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 574.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 226,263 shares of the company's stock after purchasing anJanuary 17 at 7:33 AM | marketbeat.comFY2024 Earnings Forecast for AbbVie Issued By Zacks ResearchAbbVie Inc. (NYSE:ABBV - Free Report) - Zacks Research decreased their FY2024 earnings per share estimates for AbbVie in a report released on Wednesday, January 15th. Zacks Research analyst S. Ganoria now anticipates that the company will post earnings per share of $10.06 for the year, down fromJanuary 17 at 7:05 AM | marketbeat.comOptimistic Outlook on AbbVie’s Emraclidine Strategy: A High-Reward Investment OpportunityJanuary 17 at 6:39 AM | markets.businessinsider.comCarnegie Investment Counsel Purchases 5,592 Shares of AbbVie Inc. (NYSE:ABBV)Carnegie Investment Counsel raised its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 14.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,023 shares of the company'sJanuary 17 at 6:06 AM | marketbeat.comTallon Kerry Patrick Buys New Shares in AbbVie Inc. (NYSE:ABBV)Tallon Kerry Patrick purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,721 shares of the company's stock, valued at approximately $309,00January 17 at 5:43 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Stock Position Lessened by Gateway Investment Advisers LLCGateway Investment Advisers LLC reduced its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 15.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 370,051 shares of the compJanuary 17 at 5:43 AM | marketbeat.comBFI Infinity Ltd. Makes New Investment in AbbVie Inc. (NYSE:ABBV)BFI Infinity Ltd. acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,055 shares of the company's stock, valued at approximately $365,000. AJanuary 17 at 5:43 AM | marketbeat.comMason & Associates Inc Acquires 1,499 Shares of AbbVie Inc. (NYSE:ABBV)Mason & Associates Inc boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 49.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,506 shares of the company's stock after acquiring an additioJanuary 17 at 5:34 AM | marketbeat.comAbbVie Inc. stock underperforms Thursday when compared to competitors despite daily gainsJanuary 16, 2025 | marketwatch.comHumira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimilar SurgeJanuary 16, 2025 | finance.yahoo.comAbbVie retains Humira market share above 70%: reportJanuary 16, 2025 | seekingalpha.comThe Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and PrecipioJanuary 16, 2025 | finance.yahoo.comAbbVie Inc. (NYSE:ABBV) Shares Purchased by BluePath Capital Management LLCBluePath Capital Management LLC boosted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 20.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 11,158 shares of the company's stock after acquiring an additional 1,902 shares during the periodJanuary 16, 2025 | marketbeat.comSawyer & Company Inc Sells 3,161 Shares of AbbVie Inc. (NYSE:ABBV)Sawyer & Company Inc lessened its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 19.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,260 shares of the company's stock after selling 3,161 shares during the quarter. SaJanuary 16, 2025 | marketbeat.comCampbell Newman Asset Management Inc. Cuts Stock Position in AbbVie Inc. (NYSE:ABBV)Campbell Newman Asset Management Inc. decreased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 6.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 163,808 shares of the company's stock after selliJanuary 16, 2025 | marketbeat.comWolff Wiese Magana LLC Acquires 1,750 Shares of AbbVie Inc. (NYSE:ABBV)Wolff Wiese Magana LLC increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,097 shares of the company's stock after acquiringJanuary 16, 2025 | marketbeat.comMeyer Handelman Co. Has $27.52 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV)Meyer Handelman Co. lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 154,861 shares of the company's stock after buying an additional 1,621 shares during the pJanuary 16, 2025 | marketbeat.comFounders Grove Wealth Partners LLC Acquires New Shares in AbbVie Inc. (NYSE:ABBV)Founders Grove Wealth Partners LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,380 shares of the company's stock, valued at approximatelyJanuary 16, 2025 | marketbeat.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼1.010.44▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼7932▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today JAZZ News Today CORT News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABBV Stock Alerts